文献速递神经肿瘤

静脉递送病毒载体介导脑肿瘤基质细胞基因修饰

Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.
PubMed 文献 · J Neurooncol · 2018-05-16

胶质母细胞瘤(GBM)缺乏有效疗法。研究在小鼠GBM模型中静脉注射外泌体相关AAV载体,用NF-κB响应启动子和截短胶质纤维酸性蛋白启动子分别驱动绿色荧光蛋白在肿瘤相关巨噬细胞/小胶质细胞和反应性星形胶质细胞中表达,避免外周转导;在肿瘤基质表达干扰素β可适度但显著延长生存。

要点

  • 静脉注射外泌体相关AAV载体可靶向肿瘤基质细胞。
  • NF-κB响应启动子靶向肿瘤相关巨噬细胞/小胶质细胞。
  • 截短胶质纤维酸性蛋白启动子靶向反应性星形胶质细胞。

核心结论

  • 非侵入性基因修饰肿瘤微环境是癌症治疗的有前景策略。
  • 所描述载体可能促进肿瘤基质细胞的原位基础研究。

研究设计与样本

  • 研究使用小鼠GBM模型。
  • 静脉注射外泌体相关AAV载体,由NF-κB响应启动子和截短胶质纤维酸性蛋白启动子驱动绿色荧光蛋白表达。

主要发现

  • 静脉递送实现肿瘤相关巨噬细胞/小胶质细胞和反应性星形胶质细胞的靶向转导,避免外周转导。
  • 在肿瘤基质表达干扰素β,与对照组相比,生存期取得适度但显著的延长。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The malignant primary brain tumor, glioblastoma (GBM) is generally incurable. New approaches are desperately needed. Adeno-associated virus (AAV) vector-mediated delivery of anti-tumor transgenes is a promising strategy, however direct injection leads to focal transgene spread in tumor and rapid tumor division dilutes out the extra-chromosomal AAV genome, limiting duration of transgene expression. Intravenous (IV) injection gives widespread distribution of AAV in normal brain, however poor transgene expression in tumor, and high expression in non-target cells which may lead to ineffective therapy and high toxicity, respectively. Delivery of transgenes encoding secreted, anti-tumor proteins to tumor stromal cells may provide a more stable and localized reservoir of therapy as they are more differentiated than fast-dividing tumor cells. Reactive astrocytes and tumor-associated macrophage/microglia (TAMs) are stromal cells that comprise a large portion of the tumor mass and are associated with tumorigenesis. In mouse models of GBM, we used IV delivery of exosome-associated AAV vectors driving green fluorescent protein expression by specific promoters (NF-κB-responsive promoter and a truncated glial fibrillary acidic protein promoter), to obtain targeted transduction of TAMs and reactive astrocytes, respectively, while avoiding transgene expression in the periphery. We used our approach to express the potent, yet toxic anti-tumor cytokine, interferon beta, in tumor stroma of a mouse model of GBM, and achieved a modest, yet significant enhancement in survival compared to controls. Noninvasive genetic modification of tumor microenvironment represents a promising approach for therapy against cancers. Additionally, the vectors described here may facilitate basic research in the study of tumor stromal cells in situ.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Volak A, LeRoy SG, Natasan JS, et al. Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery. J Neurooncol. 2018. PMID: 29767307. doi:10.1007/s11060-018-2889-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。